These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3564137)

  • 1. Kidney disease in blacks in North America--an overview.
    Hosten AO
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):5-8. PubMed ID: 3564137
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome in blacks: histopathologic perspectives.
    Pinn-Wiggins VW
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):49-55. PubMed ID: 3564136
    [No Abstract]   [Full Text] [Related]  

  • 3. End-stage renal disease and race: an overview and perspective.
    Ferguson R
    J Natl Med Assoc; 1991 Sep; 83(9):794-8. PubMed ID: 1942113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality of blacks and whites with end-stage renal disease attributed to hypertension.
    Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):27-31. PubMed ID: 1442772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney disease and hypertension in blacks: scope of the problem.
    Jones CA; Agodoa L
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):6-9. PubMed ID: 8465838
    [No Abstract]   [Full Text] [Related]  

  • 6. Revisiting racial differences in ESRD due to ADPKD in the United States.
    Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
    BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of end-stage renal failure in black patients starting renal replacement therapy.
    Frassinetti Fernandes P; Ellis PA; Roderick PJ; Cairns HS; Hicks JA; Cameron JS
    Am J Kidney Dis; 2000 Aug; 36(2):301-9. PubMed ID: 10922308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in the incidence of end-stage renal disease.
    Tell GS; Hylander B; Craven TE; Burkart J
    Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease in hypertensive blacks.
    Shulman NB
    J Clin Hypertens; 1987 Sep; 3(3 Suppl):85S-88S. PubMed ID: 3668604
    [No Abstract]   [Full Text] [Related]  

  • 10. Using the right medication to lower blood pressure and chance for kidney disease.
    Crook ED; Preddie DC
    Ethn Dis; 2004; 14(1):161. PubMed ID: 15002940
    [No Abstract]   [Full Text] [Related]  

  • 11. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
    Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
    Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II; Arodiwe EB; Ijoma CK
    Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and diabetic nephropathy.
    Friedman EA
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):77-81. PubMed ID: 3551257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-1984.
    Kappel DF; Van Tuinen M
    Am J Kidney Dis; 1986 Oct; 8(4):234-8. PubMed ID: 3766529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertensive end-stage renal disease in blacks: the role of end-stage renal disease surveillance.
    McClellan W
    Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):25-30. PubMed ID: 8465832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA associations in heroin-associated nephropathy.
    Haskell LP; Glicklich D; Senitzer D
    Am J Kidney Dis; 1988 Jul; 12(1):45-50. PubMed ID: 3389354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension in blacks. Is it a different disease?
    Meggs LG
    N Y State J Med; 1985 Apr; 85(4):160-1. PubMed ID: 3857494
    [No Abstract]   [Full Text] [Related]  

  • 20. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease?
    Whittle JC; Whelton PK; Seidler AJ; Klag MJ
    Arch Intern Med; 1991 Jul; 151(7):1359-64. PubMed ID: 2064486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.